Product correctly added to cart.

discount label
Nonapeptide 1 acetate
View 3D

Biosynth logo

Nonapeptide 1 acetate

CAS: 158563-45-2

Ref. 3D-BN183113

1gTo inquire
50mgTo inquire
100mgTo inquire
250mgTo inquire
500mgTo inquire
Estimated delivery in United States, on Tuesday 2 Jul 2024

Product Information

Name:
Nonapeptide 1 acetate
Synonyms:
  • Met-Pro-D-Phe-Arg-D-Trp-Phe-Lys-Pro-Val-NH2 acetate
Description:

Nonapeptide 1 acetate is an anticancer peptide that acts as a kinase inhibitor. It is a synthetic analog of a protein that is naturally found in human urine and has been used in Chinese medicinal practices for centuries. Nonapeptide 1 acetate has been shown to induce apoptosis in cancer cells by inhibiting the activity of kinases, which are enzymes involved in cell signaling pathways. This inhibition leads to the disruption of cellular processes necessary for tumor growth and survival. Nonapeptide 1 acetate is a promising candidate for cancer therapy due to its potent anticancer activity and low toxicity levels. Its efficacy as a cancer treatment has been demonstrated in preclinical studies, and it is currently being investigated further as a potential therapeutic option for various types of cancer.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Formula:
C61H87N15O9S•(C2H4O2)x
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-BN183113 Nonapeptide 1 acetate

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".